- Home
- SNY vs FI Comparison
SNY vs FI Comparison
Compare SNY & FI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNY
- FI
- Stock Information
- Founded
- SNY 1994
- FI 1984
- Country
- SNY France
- FI United States
- Employees
- SNY N/A
- FI N/A
- Industry
- SNY Biotechnology: Pharmaceutical Preparations
- FI Business Services
- Sector
- SNY Health Care
- FI Consumer Discretionary
- Exchange
- SNY Nasdaq
- FI Nasdaq
- Market Cap
- SNY 116.5B
- FI 95.0B
- IPO Year
- SNY N/A
- FI 1986
- Fundamental
- Price
- SNY $48.32
- FI $165.70
- Analyst Decision
- SNY Buy
- FI Strong Buy
- Analyst Count
- SNY 2
- FI 26
- Target Price
- SNY $62.50
- FI $226.40
- AVG Volume (30 Days)
- SNY 2.0M
- FI 4.3M
- Earning Date
- SNY 07-31-2025
- FI 07-23-2025
- Dividend Yield
- SNY 3.31%
- FI N/A
- EPS Growth
- SNY 39.56
- FI 5.73
- EPS
- SNY 5.45
- FI 5.65
- Revenue
- SNY $48,817,552,946.00
- FI $20,703,000,000.00
- Revenue This Year
- SNY $3.39
- FI $4.73
- Revenue Next Year
- SNY $7.05
- FI $8.40
- P/E Ratio
- SNY $8.86
- FI $29.35
- Revenue Growth
- SNY N/A
- FI 6.56
- 52 Week Low
- SNY $45.80
- FI $154.17
- 52 Week High
- SNY $60.12
- FI $238.59
- Technical
- Relative Strength Index (RSI)
- SNY 45.01
- FI 43.66
- Support Level
- SNY $47.87
- FI $164.09
- Resistance Level
- SNY $48.80
- FI $175.92
- Average True Range (ATR)
- SNY 0.58
- FI 2.96
- MACD
- SNY 0.10
- FI -0.43
- Stochastic Oscillator
- SNY 28.85
- FI 13.90
About SNY Sanofi ADS
Sanofi develops and markets drugs with a concentration in vaccines, immunology, oncology, cardiovascular disease, diabetes, and over-the-counter treatments. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing about 30% of total sales, but profits are shared with Regeneron. Just over 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
About FI Fiserv Inc.
Fiserv is a leading provider of core processing and complementary services, such as electronic funds transfer, payment processing, and loan processing, for US banks and credit unions, with a focus on small and midsize banks. Through the merger with First Data in 2019, Fiserv also provides payment processing services for merchants. About 10% of the company's revenue is generated internationally.